BIOMAT Database Logo BIOMAT Database Logo

o-phenylphenols: potent and orally active leukotriene B4 receptor antagonists. 1993

M J Sofia, and P Floreancig, and N J Bach, and S R Baker, and S L Cockerham, and J H Fleisch, and L L Froelich, and W T Jackson, and P Marder, and C R Roman
Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana 46285.

UI MeSH Term Description Entries
D007975 Leukotriene B4 The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function (degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism). (From Dictionary of Prostaglandins and Related Compounds, 1990) 5,12-HETE,5,12-diHETE,LTB4,Leukotriene B,Leukotriene B-4,Leukotrienes B,5,12 HETE,5,12 diHETE,B-4, Leukotriene,Leukotriene B 4
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

M J Sofia, and P Floreancig, and N J Bach, and S R Baker, and S L Cockerham, and J H Fleisch, and L L Froelich, and W T Jackson, and P Marder, and C R Roman
Discovery of novel and potent leukotriene B4 receptor antagonists. Part 1.
May 2010, Journal of medicinal chemistry,
M J Sofia, and P Floreancig, and N J Bach, and S R Baker, and S L Cockerham, and J H Fleisch, and L L Froelich, and W T Jackson, and P Marder, and C R Roman
ONO-LB-457: a novel and orally active leukotriene B4 receptor antagonist.
January 1991, Advances in prostaglandin, thromboxane, and leukotriene research,
M J Sofia, and P Floreancig, and N J Bach, and S R Baker, and S L Cockerham, and J H Fleisch, and L L Froelich, and W T Jackson, and P Marder, and C R Roman
Novel Potent Selective Orally Active S1P5 Receptor Antagonists.
March 2021, ACS medicinal chemistry letters,
M J Sofia, and P Floreancig, and N J Bach, and S R Baker, and S L Cockerham, and J H Fleisch, and L L Froelich, and W T Jackson, and P Marder, and C R Roman
Discovery of potent, orally active benzimidazole glucagon receptor antagonists.
July 2008, Bioorganic & medicinal chemistry letters,
M J Sofia, and P Floreancig, and N J Bach, and S R Baker, and S L Cockerham, and J H Fleisch, and L L Froelich, and W T Jackson, and P Marder, and C R Roman
Arylmethoxypyridines as novel, potent and orally active mGlu5 receptor antagonists.
April 2006, Bioorganic & medicinal chemistry letters,
M J Sofia, and P Floreancig, and N J Bach, and S R Baker, and S L Cockerham, and J H Fleisch, and L L Froelich, and W T Jackson, and P Marder, and C R Roman
Design, synthesis, and pharmacological evaluation of potent xanthone dicarboxylic acid leukotriene B4 receptor antagonists.
June 1993, Journal of medicinal chemistry,
M J Sofia, and P Floreancig, and N J Bach, and S R Baker, and S L Cockerham, and J H Fleisch, and L L Froelich, and W T Jackson, and P Marder, and C R Roman
Potent, orally absorbed glucagon receptor antagonists.
March 1999, Bioorganic & medicinal chemistry letters,
M J Sofia, and P Floreancig, and N J Bach, and S R Baker, and S L Cockerham, and J H Fleisch, and L L Froelich, and W T Jackson, and P Marder, and C R Roman
Leukotriene B4 receptor antagonists: the LY255283 series of hydroxyacetophenones.
May 1992, Journal of medicinal chemistry,
M J Sofia, and P Floreancig, and N J Bach, and S R Baker, and S L Cockerham, and J H Fleisch, and L L Froelich, and W T Jackson, and P Marder, and C R Roman
Discovery of cyclic guanidines as potent, orally active, human glucagon receptor antagonists.
December 2011, Bioorganic & medicinal chemistry letters,
M J Sofia, and P Floreancig, and N J Bach, and S R Baker, and S L Cockerham, and J H Fleisch, and L L Froelich, and W T Jackson, and P Marder, and C R Roman
Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists.
September 1991, Journal of medicinal chemistry,
Copied contents to your clipboard!